Yea Rames i attended the 11:15 one and that was the only one in...

Yea Rames i attended the 11:15 one and that was the only one in Melbourne. Your right Mark Diamond did mention that ANP did pick the 3 compounds that have produced 3 drugs that ANP have in ATL1101, 1102 and 1103. Yes he did say that they believed that they were the best out there. The way that Dr Cohen discussed ATL1103's potential blockbuster status with numerous indications for the drug plus the potential dominance in the acromegaly market suggests Mark may be right here. Top that with ATL1102's reemergence with the Chinese moving it forward with M.S phs2b/3 trials as well as taking stem cell and asthma indications to clinical trials does suggest that ANP's range of compounds have led to a possible range of big drugs with numerous indications. and finally yes the open label part was interesting and means there will be early signs of the way the drug is progressing in trials. Great to have another there yesterday as so much info flying around that miss parts. Great stuff.

Nice 1.7 buying today as well.